Apyx Medical Corp (NASDAQ:APYX)’s share price was up 8.3% during trading on Wednesday . The company traded as high as $7.99 and last traded at $7.94, approximately 122,176 shares changed hands during trading. A decline of 43% from the average daily volume of 214,307 shares. The stock had previously closed at $7.33.
A number of equities analysts recently commented on APYX shares. Zacks Investment Research raised Apyx Medical from a “hold” rating to a “buy” rating and set a $8.75 price target for the company in a research note on Thursday, November 14th. Piper Jaffray Companies increased their price target on Apyx Medical to $10.00 and gave the company an “overweight” rating in a research note on Monday, November 11th. Finally, ValuEngine raised Apyx Medical from a “buy” rating to a “strong-buy” rating in a research note on Tuesday. Four investment analysts have rated the stock with a buy rating and one has given a strong buy rating to the company. The company currently has a consensus rating of “Buy” and an average price target of $8.94.
The firm has a market capitalization of $272.66 million, a P/E ratio of -27.38 and a beta of 0.16. The firm has a 50 day moving average price of $7.06 and a 200-day moving average price of $6.92. The company has a current ratio of 8.73, a quick ratio of 7.93 and a debt-to-equity ratio of 0.01.
Several large investors have recently bought and sold shares of the company. BlackRock Inc. lifted its stake in shares of Apyx Medical by 372.5% in the 2nd quarter. BlackRock Inc. now owns 2,123,214 shares of the company’s stock valued at $14,268,000 after purchasing an additional 1,673,854 shares during the last quarter. Vanguard Group Inc. lifted its stake in shares of Apyx Medical by 2.7% in the 2nd quarter. Vanguard Group Inc. now owns 1,366,256 shares of the company’s stock valued at $9,181,000 after purchasing an additional 35,899 shares during the last quarter. State Street Corp lifted its stake in shares of Apyx Medical by 34.2% in the 3rd quarter. State Street Corp now owns 557,677 shares of the company’s stock valued at $3,775,000 after purchasing an additional 142,098 shares during the last quarter. Northern Trust Corp lifted its stake in shares of Apyx Medical by 55.8% in the 2nd quarter. Northern Trust Corp now owns 158,309 shares of the company’s stock valued at $1,064,000 after purchasing an additional 56,694 shares during the last quarter. Finally, P.A.W. Capital Corp bought a new stake in shares of Apyx Medical in the 2nd quarter valued at approximately $806,000. 54.20% of the stock is owned by institutional investors and hedge funds.
About Apyx Medical (NASDAQ:APYX)
Apyx Medical Corporation, a medical technology company, manufactures and sells medical devices in the cosmetic and surgical markets worldwide. It operates through two segments, Advanced Energy and original equipment manufacturing (OEM). The company develops J-Plasma, a patented plasma-based surgical product for cutting, coagulation, and ablation of soft tissue.
Further Reading: Pattern Day Trader – What is the PDT Rule?
Receive News & Ratings for Apyx Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Apyx Medical and related companies with MarketBeat.com's FREE daily email newsletter.